Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).
The company is in the process of seeking similar clearances under antitrust laws of other jurisdictions, and anticipates completing the acquisition later in the first quarter of 2011.
Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays